Surveillance for Diseases Among Immigrants and Refugees financed in part by 2014 Prevention and Publ
The program will:
1) enhance existing surveillance networks
2) evaluate the health status of refugees and/or immigrants for the purposes of informing and improving U.S.
programs for overseas and the post-arrival health assessments and interventions, such as presumptive treatment for parasitic infections; and
3) improve the health of refugees and/or immigrants undergoing U.S.
resettlement and protect the health of their receiving communities by controlling the spread of communicable diseases.
The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Program Accomplishments
Not Applicable.
Uses and Use Restrictions
Project funds may be used for costs associated with planning, organizing, conducting, and supporting surveillance, effectiveness, and health improvement programs directed toward immigrants and refugees in the United States, and for the implementation of other program elements as described in Section 050 above and through CDC allowable and unallowable expenses.
Eligibility Requirements
Applicant Eligibility
Eligibility is limited to any domestic entity providing health care services to immigrants and refugees newly arrived in the United States.
Beneficiary Eligibility
Any U.S. state, political subdivision and U.S. territories and other public entities providing healthcare services to newly arrived refugees and immigrants will benefit.
Credentials/Documentation
No Credentials or documentation are required. This program is excluded from coverage under OMB Circular No. A-87.
Aplication and Award Process
Preapplication Coordination
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
12372.
Application Procedures
OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program.
Award Procedures
All applications that are complete and responsive to competitive supplemental grant and cooperative agreement announcements will undergo an objective review process, receive a written critique and be scored according to published review criteria. Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized CDC Grants Management Officer.
Deadlines
Contact the headquarters or regional office, as appropriate, for application deadlines.
Authorization
Patient Protection and Affordable Care Act (PL 111-148); Public Health Service Act, Sections 301 and 317(k)(1) [42 U.S.C. 242l and 247b(k)(1)], as amended.
Range of Approval/Disapproval Time
From 60 to 90 days.
Appeals
Not Applicable.
Renewals
> 180 Days. Renewals will be based upon the conditions in the funding announcement and are subject to the availability of funds.
Assistance Considerations
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance
Financial assistance is typically available for a 12-month budget period and 60-month project period. Method of awarding/releasing assistance: lump sum.
Post Assistance Requirements
Reports
No program reports are required.
No cash reports are required.
A Semi-annual Progress Report is required per Public Health and Prevention Fund guidelines.
An Interim Progress Report is required as part of a continuation application.
A Federal Financial Report is due 90 days after the end of every Budget Period.
A Final Progress Report and Federal Financial Report is required 90 days after the end of the Project Period.
No expenditure reports are required.
No performance monitoring is required.
Audits
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133.
Records
No Data Available.
Financial Information
Account Identification
75-0943-0-1-551; 75-0949-0-1-550.
Obigations
(Cooperative Agreements) FY 13 $0; FY 14 est $187,500; and FY 15 est $187,500
Range and Average of Financial Assistance
Awards will range from approximately $25,000 to $150,000 with an average of approximately $80,000.
Regulations, Guidelines, and Literature
Not Applicable.
Information Contacts
Regional or Local Office
None.
Headquarters Office
Andrew J. Demma 1600 Clifton Rd, MS E-03, Atlanta, Georgia 30333 Email: ADemma@cdc.gov Phone: 404-639-3774
Criteria for Selecting Proposals
Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff and for responsiveness jointly by the National Center for Emerging and Zoonotic Diseases and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified if the application did not meet submission requirements.
Social Entrepreneurship
Spotlight
The Social Innovators of 2014
For 2014, the Schwab Foundation for Social Entrepreneurship has recognized 37 individuals for their outstanding work in the field of social enterprise.
